Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Current Nutrition Reports
Published in: Current Nutrition Reports 1/2016

01-03-2016 | Cancer (MF Leitzmann, Section Editor)

Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

Authors: Mandi M. Hopkins, Kathryn E. Meier

Published in: Current Nutrition Reports | Issue 1/2016

Login to get access

Abstract

Omega-3 fatty acids (n-3 FAs) are thought to have many health benefits, among them are prevention of heart disease, depression, and various types of cancer, including prostate cancer. Basic and animal research studies have established that treatment with, or diets high in, n-3 FAs inhibit the progression of prostate cancer. Although several human epidemiological studies have come to the same conclusion, the results between epidemiological studies are not consistent. Some epidemiological studies have even found a positive correlation between prostate cancer and n-3 FAs, although the majority of epidemiological studies and meta-analyses have found no correlation. This discrepancy has a number of potential causes, the foremost being that human studies have considerably more variables to contend with than studies involving cell cultures or animals. The variations between epidemiological studies point to the need for better controlled, larger-scale, epidemiological studies, and more preclinical studies to elucidate the mechanism of action of n-3 FAs.
Literature
1.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Gerber M. Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr Suppl. 2012;2:S228–239.CrossRef
3.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMed
4.
Nithipatikom K, Campbell WB. Roles of eicosanoids in prostate cancer. Futur Lipidol. 2008;3(4):453–67.CrossRef
5.
Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed Res Int. 2013;824563:1–10.
6.
7.
Meng H, Shen Y, Shen J, Zhou F, Shen S, Das UN. Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro. Lipids Health Dis. 2013;12:160–74.CrossRefPubMedPubMedCentral
8.
Bishop KS, Erdrich S, Karunasinghe N, Han DY, Zhu S, Jesuthasan A, et al. An investigation into the association between DNA damage and dietary fatty acid in men with prostate cancer. Nutrients. 2015;7:405–22.CrossRefPubMedPubMedCentral
9.
Park J-M, Kwon S-H, Han Y-M, Hahm K-B, Kim E-H. Omega-3 polyunsaturated fatty acids as potential chemopreventive agent for gastrointestinal cancer. J Cancer Prev. 2013;18(3):1–8.
10.
DiNicolantonio JJ, McCarty MF, Chatterjee S, Lavie CJ, O’Keefe JH (2014) A higher dietary ratio of long-chain omega-3 to total omega-6 fatty acids for prevention of COX-2-dependent adenocarcinomas. Nutr & Cancer 0(0): 1–6
11.
Fabian CJ and Kimler BF (2013) Marine-derived omega-3 fatty acids: fishing for clues for cancer prevention. ASCO 2013 Educational Book: 97–101.
12.
Kang JX, Liu A. The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis. Cancer Metastasis Rev. 2013;32:201–10.CrossRefPubMed
13.••
Nabavi SF, Bilotto S, Russo GL, Orhan IE, Habtemariam S, Daglia M, et al. Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. Cancer Metastasis Rev. 2015;34:359–80. This review is particularly comprehensive and provides an excellent overview of n-3 FAs in general, as well as their relationship to various cancers and diseases.CrossRefPubMed
14.
Chung BH, Mitchell SH, Zhang J-S, Young CYF. Effects of DHA and EPA on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis. 2001;22(8):1201–6.CrossRefPubMed
15.
Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, et al. Effect of dietary polyunsaturated FAs on castration-resistant Pten-null prostate cancer. Carcinogenesis. 2012;33(2):404–12.CrossRefPubMedPubMedCentral
16.
Hughes-Fulford M, Chen Y, Tjandrawinata RR. Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis. 2001;22(5):701–7.CrossRefPubMed
17.
Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs. Br J Cancer. 2006;94:842–53.CrossRefPubMedPubMedCentral
18.
Lu Y, Nie D, Witt WT, Chen Q, Shen M, Xie H, et al. Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 β phosphorylation. Mol Cancer Ther. 2008;7:3203–11.CrossRefPubMed
19.
Edwards IJ, O’Flaherty JT. Omega-3 fatty acids and PPARγ in cancer. PPAR Res. 2008;358052:1–14.CrossRef
20.
Kalish BT, Fallon EM, Puder M. A tutorial on fatty acid biology. J Parenter Enter Nutr. 2012;36:380–90.CrossRef
21.
Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83:217–44.CrossRefPubMed
22.
Comba A, Lin Y-H, Eynard AR, Valentich MA, Fernandez-Zapico ME, Pasqualini ME. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev. 2011;30(3–4):325–42.CrossRefPubMedPubMedCentral
23.
24.
Bell GA, Kantor ED, Lampe JW, Kristal AR, Heckbert SR, White E. Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality. Am J Epidemiol. 2014;179(6):710–21.CrossRefPubMedPubMedCentral
25.
Patel D, Thevenet-Morrison K, van Wijngaarden E (2014) Omega-3 polyunsaturated fatty acid intake through fish consumption and prostate specific antigen level: results from the 2003 to 2010 national health and examination survey. Prostaglandins, Leukotrienes Essent Fatty Acids, 1–6
26.
Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr. 2012;32:203–27.CrossRefPubMed
27.•
Liu Z, Hopkins MM, Zhang Z, Quisenberry CB, Fix LC, Galvan BM, et al. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells. J Pharmacol Exp Ther. 2015;352:1–15. This paper provides evidence of a novel receptor-mediated mechanism of action for n-3 FAs in prostate cancer cells. The doses of n-3 FA used are lower than those used in many other cell culture studies.CrossRef
28.
Al-Zaubai N, Johnstone CN, Leong MM, Li J, Rizzacasa M, Stewart AG. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor. J Pharmacol Exp Ther. 2014;351:172–80.CrossRefPubMed
29.
Gu Z, Wu J, Wang S, Suburu J, Chen H, Thomas MJ, et al. Polyunsaturated fatty acids affect the localization and signaling of PIP3/Akt in prostate cancer cells. Carcinogenesis. 2013;34:1968–75.CrossRefPubMedPubMedCentral
30.•
Shin S, Jing K, Jeong S, Kim N, Song K-S, Heo J-Y, Park J-H, Seo K-S, Han J, Park J-I, Kweon G-R, Park S-K, Wu T, Hwang B-D, Lim K (2013) The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53. BioMed Research International 2013: 1–11. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer.
31.•
Li C-C, Hou Y-C, Yeh C-L, Yeh S-L. Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages. PLoS ONE. 2014;9(6):e99630. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer.CrossRefPubMedPubMedCentral
32.•
Wang X, Breeze A, Kulka M. N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells. Cancer Immunol Immunother. 2015;64:249–58. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer.CrossRefPubMed
33.
Eser PO, Vanden Heuvel JP, Araujo J, Thompson JT. Marine-and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation. Mol Clin Oncol. 2013;1:444–52.PubMedPubMedCentral
34.
Lupton JR and Chapkin RS (2004) Chemoprotective effects of omega-3 fatty acids. Cancer Chemoprevention: Cancer Drug Discovery and Development, pp 591–608
35.
Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83:1467S–76S.PubMed
36.
Davidson MH. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr Opin Lipidol. 2013;24:467–74.CrossRefPubMed
37.
Connolly JM, Coleman M, Rose DP. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer. 1997;29(2):114–9.CrossRefPubMed
38.
Kobayashi N, Barnard J, Henning SM, Elashoff D, Reddy ST, Cohen P, et al. Effect of altering dietary n-6/n-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res. 2006;12(15):4662–70.CrossRefPubMedPubMedCentral
39.
Akinsete JA, Ion G, Witte TR, Hardman WE. Consumption of high n-3 FA diet suppressed prostate tumorigenesis in C3(1) Tag mice. Carcinogenesis. 2012;33(1):140–8.CrossRefPubMedPubMedCentral
40.
Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC, et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:64–7.PubMed
41.••
Fu Y-Q, Zheng J-S, Yang B, Li D. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose–response meta-analysis of prospective cohort studies. J Epidemiology. 2015;25(4):261–74. This is a very thorough meta-analysis of the relationship between n-3 FAs and prostate cancer.CrossRef
42.
Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58(1):47–52.CrossRefPubMed
43.
Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:1364–70.CrossRefPubMed
44.
Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res. 2009;15:2559–66.CrossRefPubMedPubMedCentral
45.
Aronson WJ, Kobayashi N, Barnard RJ, Henning S, Jardack PM, Liu B, et al. Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy. Cancer Prev Res. 2011;4(12):2062–71.CrossRef
46.
Moreel X, Allaire J, Leger C, Caron A, Labonte M-E, Lamarche B, et al. Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance. Cancer Prev Res. 2014;7(7):766–76.CrossRef
47.
Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, et al. Plasma phospholipids FAs and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013;105:1132–41.CrossRefPubMedPubMedCentral
48.
Hoffman R and Glew R (2013) Omega-3 fatty acids and prostate cancer: study and stories off-base. Health Care Journalism
49.
Chua ME, Sio MCD, Sorongon MC, Morales Jr ML. The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: a meta-analysis. Can Urol Assoc J. 2013;7(5–6):e333–43.PubMedPubMedCentral
50.
Sorongon-Legaspi MK, Chua M, Sio MC, Morales Jr M. Blood level omega-3 fatty acids as risk determinant molecular biomarker for prostate cancer. Prostate Cancer. 2013;2013:1–15.CrossRef
51.
Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E. A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control. 2007;18:1107–21.CrossRefPubMed
52.
Shannon J, O’Malley J, Mori M, Garzotto M, Palma AJ, King IB. Erythrocyte fatty acids and prostate cancer risk: a comparison of methods. Prostaglandins Leukot Essent Fat Acids. 2010;83:161–9.CrossRef
53.
Brouwer IA, Geleijnse JM, Klaasen VM, Smit LA, Giltay EJ, de Goede J, et al. Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial. PLoS ONE. 2013;8(12), e81519.CrossRefPubMedPubMedCentral
54.
MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295:403–15.CrossRefPubMed
55.
Crowe FL, Appleby PN, Travis RC, Barnett M, Brasky TM, Bueno-de-Mesquita B, et al. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. J Natl Cancer Inst. 2014;106(9):dju240.CrossRefPubMedPubMedCentral
56.••
Alexander DD, Bassett JK, Weed DL, Barrett EC, Watson H, Harris W. Meta-analysis of long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) and prostate cancer. Nutr Cancer. 2015;67(4):543–54. This is an especially meticulous meta-analysis pf n-3 FAs and human prostate cancer with good parameters and discussion.CrossRefPubMedPubMedCentral
57.
Lovegrove C, Ahmed K, Challavombe B, Khan MS, Popert R, Dasgupta P. Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants. Int J Clin Pract. 2015;69(1):87–105.CrossRefPubMed
58.
Mathias RA, Pani V, Chilton FH. Genetic variants in the FADS gene: implications for dietary recommendations for fatty acid intake. Curr Nutr Rep. 2014;3(2):139–48.CrossRefPubMedPubMedCentral
59.
Hester AG, Murphy RC, Uhlson CJ, Ivester P, Lee TC, Sergeant S, et al. Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans. J Biol Chem. 2014;289(32):22482–9.CrossRefPubMedPubMedCentral
60.
Chilton FH, Murphy RC, Wilson BA, Sergeant S, Ainsworth H, Seeds MC, et al. Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases. Nutrients. 2014;6:1993–2022.CrossRefPubMedPubMedCentral
61.
62.
Zhang P, He X, Tan J, Zhou X, Zou L. β-Arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression. Oncol Rep. 2011;26:1471–7.PubMed
Metadata
Title
Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk
Authors
Mandi M. Hopkins
Kathryn E. Meier
Publication date
01-03-2016
Publisher
Springer US
Published in
Current Nutrition Reports / Issue 1/2016
Electronic ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-016-0150-1

Other articles of this Issue 1/2016

Current Nutrition Reports 1/2016 Go to the issue

Cancer (MF Leitzmann, Section Editor)

Obesity in Relation to Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus

Dietary Patterns and Behavior (LM Steffen, Section Editor)

Associations Between Food Restriction and Pressure-to-Eat Parenting Practices and Dietary Intake in Children: a Selective Review of the Recent Literature

Cancer (MF Leitzmann, Section Editor)

The Association Between Adiposity and Survival in Patients with Colorectal Cancer

Dietary Patterns and Behavior (LM Steffen, Section Editor)

Dietary Patterns in the Frail Elderly

Cancer (MF Leitzmann, Section Editor)

Adult Height in Relation to the Incidence of Cancer at Different Anatomic Sites: the Epidemiology of a Challenging Association

Dietary Patterns and Behavior (LM Steffen, Section Editor)

The Relationship Between Food Insecurity, Dietary Patterns, and Obesity

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits